Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
SciBase's EIS Technology Selected as Primary Endpoint in NIH Skin Barrier Study
15 Oct 2026
PR Newswire Association LLC.
SciBase has secured first US payer coverage with major insurance company, aims for global lead in non-invasive skin assessment
15 Oct 2026
PR Newswire Association LLC.
SciBase secures first payer coverage with Highmark, marking a major commercial inflection point
14 Oct 2026
PR Newswire Association LLC.
Akiram Therapeutics: First clinical results from AKIR001 to be presented at EANM 2026
13 Oct 2026
PR Newswire Association LLC.
On the 12th Edition of Global Patient Week Bristol Myers Squibb and Saudi Schizophrenia Association 'Ehtiwaa' Collaborate to Support People Living with Schizophrenia Through the 'Small Wins' Initiative
12 Oct 2026
PR Newswire Association LLC.
UK pathology provider Diagnexia chooses Sectra to speed up pathology reporting for the NHS
12 Oct 2026
PR Newswire Association LLC.
SciBase's rights issue registered, conversion of BTA into shares
09 Oct 2026
PR Newswire Association LLC.
Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133
08 Oct 2026
PR Newswire Association LLC.
SciBase: Recalculation of warrants of series TO 2 following rights issue
07 Oct 2026
PR Newswire Association LLC.
Natural Cycles deepens investment in Canada following 3x user growth
07 Oct 2026
PR Newswire Association LLC.
SciBase resolves on a set-off issue of shares to the guarantor in connection with the completed rights issue
07 Oct 2026
PR Newswire Association LLC.
Beactica Therapeutics selects BEA-28 as a preclinical candidate, a first-in-class TEAD degrader for biomarker-selected cancers
06 Oct 2026
PR Newswire Association LLC.
Driving Community Health: Bristol Myers Squibb, Emirates Thalassemia Society and Dubai Science Park Host the 6th 'Help Save a Life' Blood Donation Drive
05 Oct 2026
GlobeNewswire
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series
06 Aug 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
06 Aug 2026
GlobeNewswire
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
06 Aug 2026
GlobeNewswire
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
05 Aug 2026
GlobeNewswire
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG
05 Aug 2026
GlobeNewswire
Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook
04 Aug 2026
GlobeNewswire
Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026
04 Aug 2026
GlobeNewswire
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
03 Aug 2026
GlobeNewswire
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31 Jul 2026
GlobeNewswire
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
31 Jul 2026
GlobeNewswire
Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance
30 Jul 2026
GlobeNewswire
BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets
29 Jul 2026
Upcoming Events All Events
- October 2026
- Queensland: AusBiotech Invest
- Queensland: AusBiotech International Conference
- New York City: BioFuture 2026